Drug class in one race

ribonucleotide reductase / DNA polymerase (dCTP competition) drugs for Non-Small Cell Lung Cancer

2 tracked ribonucleotide reductase / DNA polymerase (dCTP competition) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the ribonucleotide reductase / DNA polymerase (dCTP competition) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

Head-to-head evidence: FF-10832 vs Gemcitabine

← all ribonucleotide reductase / DNA polymerase (dCTP competition) drugs